Perioperative risk of aortic valve replacement after coronary artery bypass grafting

Thorac Cardiovasc Surg. 2006 Apr;54(3):157-61. doi: 10.1055/s-2005-872974.

Abstract

Objective: To evaluate the operative risk of aortic valve replacement (AVR) after coronary artery bypass grafting (CABG).

Methods: Twenty patients (sixteen male, four female) underwent AVR 1.5-20 years (mean: 8.2) after CABG.

Results: Patients had received a mean number of four bypass grafts (2-5) with the use of the left internal thoracic artery in seventeen patients. Mean age at the time of AVR was 70.5 years (57-82). All patients suffered from an aortic stenosis with a mean orifice area of 0.74 cm (2) (0.34-1.1) and a mean pressure gradient of 52.4 mm Hg (22-78). Ten mechanical (mean diameter 23.6 mm, 21-27) and ten biological (22.1 mm, 19-25) prostheses were implanted. Mean duration of surgery, cardiopulmonary bypass (CPB) and cross-clamp time were 322.1 (205-645), 169.2 (87-411), and 77.1 (46-128) minutes, respectively. Fourteen patients had an uneventful postoperative course. A temporary neurological impairment, renal failure, and re-intubation for respiratory insufficiency for nine hours occurred in one patient each. Two patients died postoperatively (day 3 and 10) due to multiple cerebral infarctions. One patient required a replacement of the ascending aorta in deep hypothermia and re-implantation of the bypasses. He suffered from gastrointestinal bleeding on postoperative day 14 and expired on day 81 because of multi-organ failure.

Conclusion: Aortic valve replacement after coronary artery bypass grafting is associated with an enhanced perioperative risk requiring meticulous decision-making and a sophisticated operative technique.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Valve Stenosis / surgery*
  • Coronary Artery Bypass*
  • Coronary Stenosis / surgery*
  • Female
  • Heart Valve Prosthesis Implantation*
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Reoperation
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Treatment Outcome